Previous 10 | Next 10 |
Both opportunity and risk assessments can be drawn from looking at the price action in Amedisys (NASDAQ: AMED). This is a practice commonly referred to as reading the charts. The summary data for AMED below demonstrates this, and there are trading plans that help inves...
Amedisys delivers another strong quarter despite regulatory shifts and COVID-19-related headwinds. Heading into fiscal 2021, the latest guidance indicates the post-COVID-19 recovery is taking shape, although there remains plenty of room for upside surprises. Backed by a solid bala...
Amedisys (AMED) repurchased ~$73M in stock, commencing from Mar.1.In late 2020, the company board authorized up to $100M in share repurchases through Dec. 31, 2021."Our pipeline in both home health and hospice remains very full and we look forward to getting a few of these deals across t...
BATON ROUGE, La., March 15, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, has repurchased approximately $73 million in stock beginning Monday, March 1. Late in 2020, the Amedisys Board of Directors authorized up to...
This Amedisys (NASDAQ: AMED) report helps investors and traders identify both opportunity, and potential red flags, by using the price action of the stock. The trading plans for AMED have risk controls, and that make these observations both opportunistic and defensive, but the dat...
According to Stock Traders Daily, a 2-year industry veteran, investors can use the price action in Amedisys (NASDAQ: AMED) to foretell upcoming changes. A current example is provided below. There are trading plans for AMED, but the data on this page does not update in real time. I...
BATON ROUGE, La., March 01, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, Chief Executive Officer, will present at both the 42 nd Annual Raymond James Institutiona...
The following slide deck was published by Amedisys, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Amedisys, Inc. 2020 Q4 - Results - Earnings Call Presentation
Amedisys, Inc. (AMED) Q4 2020 Earnings Conference Call February 25, 2021 11:00 ET Company Participants Nick Muscato - Investor Relations Paul Kusserow - Chairman and Chief Executive Officer Chris Gerard - President and Chief Operating Officer Scott Ginn - Executive Vice President and Chief Fi...
Image source: The Motley Fool. AMEDISYS Inc (NASDAQ: AMED) Q4 2020 Earnings Call Feb 25, 2021 , 11:00 a.m. ET Operator Continue reading For further details see: AMEDISYS Inc (AMED) Q4 2020 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 Net service revenue increased $38.2 million to...
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Amedisys, Inc. (NASDAQ: AMED) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.74% on the day to $95.23. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates thr...